Related Experiment Video
Updated: Jun 5, 2026

Exergaming in Older People Living with HIV Improves Balance, Mobility and Ameliorates Some Aspects of Frailty
Published on: October 6, 2016
Management of metabolic complications and cardiovascular risk in HIV-infected patients
Francisco Blanco1, Jesús San Román, Eugenia Vispo
1Hospital Carlos III, Madrid, Spain. fblancoq@gmail.com
Insights
Highly active antiretroviral therapy (HAART) has reduced AIDS deaths, but cardiovascular disease risk is increasing in people with HIV. Early detection and management of risk factors like hypertension and lipid abnormalities are crucial for better outcomes.
Area of Science:
- Infectious Diseases
- Cardiology
- Public Health
Background:
- Highly Active Antiretroviral Therapy (HAART) has significantly decreased AIDS-related mortality.
- Cardiovascular disease (CVD) mortality is increasing in HIV-infected individuals, driven by metabolic complications.
- Both HIV infection and antiretroviral drugs contribute to elevated cardiovascular risk.
Purpose of the Study:
- To highlight the rising cardiovascular risk in the aging HIV-infected population.
- To emphasize the need for early diagnosis and management of cardiovascular risk factors in HIV patients.
- To outline strategies for mitigating cardiovascular risk in this cohort.
Main Methods:
- Regular screening for lipid abnormalities, hyperglycemia, hypertension, overweight, renal disease, and smoking in HIV-infected individuals.
- Absolute coronary heart disease risk assessment.
- Implementation of comprehensive therapeutic measures and lifestyle modifications.
- Consideration of metabolic-friendly antiretroviral agents and management guidelines for general population.
Main Results:
- Metabolic complications are common in HIV-positive individuals, increasing cardiovascular risk.
- Aging HIV population faces a growing impact of cardiovascular events on survival.
- Proactive management of risk factors is essential to prevent future cardiovascular complications.
Conclusions:
- Comprehensive management of cardiovascular risk factors, including metabolic abnormalities and hypertension, is critical for HIV-infected individuals.
- Promoting healthy lifestyle habits and smoking cessation are vital components of care.
- Addressing preventable factors can significantly reduce the increased cardiovascular risk in this population.
Abstract:
As result of the great benefit of HAART, AIDS-related deaths have dramatically declined during the last decade in HIV-infected individuals. However, mortality due to non-AIDS conditions and particularly cardiovascular events seems to be on the rise in this population. Metabolic complications and other conditions responsible for increased cardiovascular risk are common in HIV persons. Moreover, antiretroviral medications and HIV itself might play a role in further increasing cardiovascular risk. As the HIV population is aging, a growing impact of cardiovascular events on survival can be expected. Therefore, early diagnosis and treatment of predisposing cardiovascular risk factors is warranted in this population. In this way, all HIV-infected individuals should be evaluated regularly for lipid abnormalities, hyperglycemia, arterial hypertension, overweight, renal disease, and smoking. The individual´s absolute risk for coronary heart disease must be defined, and comprehensive therapeutic measures should be undertaken in order to minimize future complications in subjects with significant cardiovascular risk. Lifestyle habits must be encouraged, including healthy diet and exercise. Switches in antiretroviral regimens using metabolic-friendly agents should also be considered for managing mild metabolic abnormalities in lipids and glucose, as long as suppression of viral replication is not compromised. The management of overt lipid disorders, diabetes, and hypertension basically must follow the guidelines applied to the general population and specific drugs administered, taking into account the potential for drug interactions with antiretroviral agents. In summary, efforts for reducing the increased cardiovascular risk characteristically seen in HIV-infected individuals are warranted, and preventable factors, including adequate management of metabolic abnormalities and hypertension, along with promotion of lifestyle habits and smoke cessation, should no longer be neglected.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Myocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Complications of Diabetes Mellitus
Heart Failure V: Medical Management
Cryptococcal Meningitis

